CoChat

Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome

Open access
Vogg, Nora, Kurlbaum, Max, Deutschbein, Timo, Gräsl, Benedict, Fassnacht, Martin, Kroiss, Matthias · 2021 · Clinical Chemistry
Cited by 38

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background: The dexamethasone suppression test (DST) is the recommended first-tier test for suspected Cushing syndrome (CS). Missed dexamethasone intake or insufficient dexamethasone serum exposure may yield false positive results. Quantification of serum dexamethasone in DST samples may therefore improve test performance. Methods: Simultaneous quantification of dexamethasone and cortisol by liquid chromatography-tandem mass spectrometry in 400 DST serum samples (100 overt CS, 200 excluded CS, 100 adrenal incidentalomas with (possible) autonomous cortisol secretion, AI-ACS) randomly selected within the indication groups. The 2.5th percentile of dexamethasone in patients with excluded CS was considered the lower limit of normal (LLN). Results: Serum dexamethasone varied from undetectable to 20.2 ng/mL with a median of 4.8 ng/mL (95% CI 4.5-5.1 ng/mL). Dexamethasone was undetectable in only 16 patients (4%), suggesting non-compliance. The dexamethasone LLN was 1.8 ng/mL (4.6 nmol/L). Decreased glomerular filtration rate and diabetes mellitus were associated with higher serum dexamethasone concentration, while body mass index, sex, age, nicotine, and oral contraceptives had no significant effect. By excluding the 27 samples with dexamethasone <LLN and applying the method-specific cortisol cutoff of 2.4 µg/dL (66 nmol/L) to samples with suspected CS, the clinical specificity for CS increased from 67.5% to 92.4% while preserving 100% clinical sensitivity. Among 100 AI-ACS samples (defined by immunoassay), 4 samples had dexamethasone <1.8 ng/mL and 14 samples had cortisol <2.4 µg/dL, which excluded autonomous cortisol secretion. Conclusions: Quantification of dexamethasone and method-specific cortisol cutoffs in DST samples may reduce the false positive rate and lower the proportion of patients requiring further workup.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinchem/hvab056

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 21

  1. Lacroix, 2015, Cushing's syndrome, Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 · DOI · Paper page
  2. Pivonello, 2016, Complications of Cushing's syndrome: State of the art, Lancet Diabetes Endocrinol, 4, 611, 10.1016/S2213-8587(16)00086-3 · DOI · Paper page
  3. Barbot, 2020, Cushing's syndrome: overview of clinical presentation, diagnostic tools and complications, Best Pract Res Clin Endocrinol Metab, 34, 101380, 10.1016/j.beem.2020.101380 · DOI · Paper page
  4. Stalla, 2019, "The adrenal gland: central relay in health and disease - current challenges and perspectives 2018" - Cushing's disease, Exp Clin Endocrinol Diabetes, 127, 147, 10.1055/a-0664-7632 · DOI
  5. Loriaux, 2017, Diagnosis and differential diagnosis of Cushing's syndrome, N Engl J Med, 377, e3, 10.1056/NEJMc1705984 · DOI
  6. Nieman, 2015, Cushing's syndrome: Update on signs, symptoms and biochemical screening, Eur J Endocrinol, 173, M33, 10.1530/EJE-15-0464 · DOI · Paper page
  7. Guthrie, 1991, The impact of dexamethasone pharmacokinetics on the DST: a review, Psychopharmacol Bull, 27, 565
  8. Vilar, 2007, Pitfalls in the diagnosis of Cushing's syndrome, Arq Bras Endocrinol Metab, 51, 1207, 10.1590/S0004-27302007000800006 · DOI · Paper page
  9. Morris, 1986, Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders, Br J Psychiatry, 148, 66, 10.1192/bjp.148.1.66 · DOI · Paper page
  10. O'Sullivan, 1997, Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects, Biol Psychiatry, 41, 574, 10.1016/S0006-3223(96)00094-7 · DOI
  11. Asvold, 2012, Association between posttest dexamethasone and cortisol concentrations in the 1 mg overnight dexamethasone suppression test, Endocr Connect, 1, 62, 10.1530/EC-12-0047 · DOI
  12. Soldin, 2009, Steroid hormone analysis by tandem mass spectrometry, Clin Chem, 55, 1061, 10.1373/clinchem.2007.100008 · DOI · Paper page
  13. Hempen, 2012, Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry, Ann Clin Biochem, 49, 170, 10.1258/acb.2011.011004 · DOI · Paper page
  14. Hawley, 2018, Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification, Ann Clin Biochem, 55, 665, 10.1177/0004563218766566 · DOI
  15. Ceccato, 2020, Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation, J Endocrinol Invest, 43, 1105, 10.1007/s40618-020-01197-6 · DOI
  16. Reed, 1971, Influence of statistical method used on the resulting estimate of normal range, Clin Chem, 17, 275, 10.1093/clinchem/17.4.275 · DOI · Paper page
  17. Jackson, 2019, In this issue–May 2019: West Nile virus in horses. Treating horses with dexamethasone via nebulisation. Animal hoarding in NSW. Dangers of powdered washing soda for emesis in dogs. Pneumocystis in a dog following toceranib phosphate. Oxalate nephrosis in koalas, Aust Vet J, 97, 129, 10.1111/avj.12818 · doi:10.1111/avj.12818
  18. Bashir, 2020, Comparative safety, bioavailability, and pharmacokinetics of oral dexamethasone, 4-mg and 20-mg tablets, in healthy volunteers under fasting and fed conditions: a randomized open-label, 3-way crossover study, Clin Lymphoma Myeloma Leuk, 20, 768, 10.1016/j.clml.2020.06.022 · doi:10.1016/j.clml.2020.06.022
  19. Ritzel, 2015, ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test, Eur J Endocrinol, 173, 197, 10.1530/EJE-14-0912 · DOI · Paper page
  20. Rose, 1981, Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics, J Pharmacokinet Biopharm, 9, 1, 10.1007/BF01059339 · DOI
  21. Bancos, 2020, Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study, Lancet Diabetes Endocrinol, 8, 773, 10.1016/S2213-8587(20)30218-7 · DOI · Paper page

Cited by

See all 38

Metadata

Authors
Vogg, N., Kurlbaum, M., Deutschbein, T., Gräsl, B., Fassnacht, M., & Kroiss, M.
Venue
Clinical Chemistry
Published
2021-05-17
Volume
67
Issue
7
Pages
998-1007
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W3161394254
Cited by
38
References
12
FWCI
3.12
Type
journal article
Language
en
Open access
hybrid
Funders
  • Deutsche Forschungsgemeinschaft (314061271)
  • Bayerische Forschungsstiftung, Forschungsverbund FORTiTher (AZ-1365-18)
  • German Excellence Initiative to the Graduate School of Life Sciences
  • University of Würzburg

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome. https://app.cochat.ai/papers/10.1093/clinchem/hvab056
The paper
Vogg, N., Kurlbaum, M., Deutschbein, T., Gräsl, B., Fassnacht, M., & Kroiss, M. (2021). Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvab056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.